Literature DB >> 32792413

Addressing Polypharmacy in Outpatient Dialysis Units.

Marisa Battistella1,2, Patrick Ng3,2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32792413      PMCID： PMC7792641          DOI： 10.2215/CJN.05270420

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

Review 1.  Evaluating the public health impact of health promotion interventions: the RE-AIM framework.

Authors:  R E Glasgow; T M Vogt; S M Boles
Journal:  Am J Public Health       Date:  1999-09       Impact factor: 9.308

Review 2.  Association between polypharmacy and death: A systematic review and meta-analysis.

Authors:  Nattawut Leelakanok; Andrea L Holcombe; Brian C Lund; Xiaomei Gu; Marin L Schweizer
Journal:  J Am Pharm Assoc (2003)       Date:  2017-08-05

3.  The prescribing cascade revisited.

Authors:  Paula A Rochon; Jerry H Gurwitz
Journal:  Lancet       Date:  2017-05-04       Impact factor: 79.321

4.  Determination and quantification of content validity.

Authors:  M R Lynn
Journal:  Nurs Res       Date:  1986 Nov-Dec       Impact factor: 2.381

5.  Reducing inappropriate polypharmacy: the process of deprescribing.

Authors:  Ian A Scott; Sarah N Hilmer; Emily Reeve; Kathleen Potter; David Le Couteur; Deborah Rigby; Danijela Gnjidic; Christopher B Del Mar; Elizabeth E Roughead; Amy Page; Jesse Jansen; Jennifer H Martin
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

6.  Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.

Authors:  Caitlin McIntyre; Rory McQuillan; Chaim Bell; Marisa Battistella
Journal:  Am J Kidney Dis       Date:  2017-04-14       Impact factor: 8.860

Review 7.  Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable.

Authors:  Joel A Salazar; Ivy Poon; Mridula Nair
Journal:  Expert Opin Drug Saf       Date:  2007-11       Impact factor: 4.250

Review 8.  Patient barriers to and enablers of deprescribing: a systematic review.

Authors:  Emily Reeve; Josephine To; Ivanka Hendrix; Sepehr Shakib; Michael S Roberts; Michael D Wiese
Journal:  Drugs Aging       Date:  2013-10       Impact factor: 3.923

Review 9.  Medication withdrawal trials in people aged 65 years and older: a systematic review.

Authors:  Shoba Iyer; Vasi Naganathan; Andrew J McLachlan; David G Le Couteur
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  A Province-wide, Cross-sectional Study of Demographics and Medication Use of Patients in Hemodialysis Units Across Ontario.

Authors:  Marisa Battistella; Racquel Jandoc; Jeremy Y Ng; Eric McArthur; Amit X Garg
Journal:  Can J Kidney Health Dis       Date:  2018-03-13
  10 in total
  5 in total

Review 1.  Less is More: Deprescribing Medications in Older Adults with Kidney Disease: A Review.

Authors:  Dinushika Mohottige; Harold J Manley; Rasheeda K Hall
Journal:  Kidney360       Date:  2021-07-09

2.  Deprescribing Opportunities for Hospitalized Patients With End-Stage Kidney Disease on Hemodialysis: A Secondary Analysis of the MedSafer Cluster Randomized Controlled Trial.

Authors:  Joseph Moryousef; Émilie Bortolussi-Courval; Tiina Podymow; Todd C Lee; Emilie Trinh; Emily G McDonald
Journal:  Can J Kidney Health Dis       Date:  2022-05-13

Review 3.  Polypharmacy and Mental Health Issues in the Senior Hemodialysis Patient.

Authors:  Maša Knehtl; Tadej Petreski; Nejc Piko; Robert Ekart; Sebastjan Bevc
Journal:  Front Psychiatry       Date:  2022-05-12       Impact factor: 5.435

4.  Prognostic impact of polypharmacy by drug essentiality in patients on hemodialysis.

Authors:  Mineaki Kitamura; Kosei Yamaguchi; Yuki Ota; Satoko Notomi; Maya Komine; Rika Etoh; Takashi Harada; Satoshi Funakoshi; Hiroshi Mukae; Tomoya Nishino
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.379

5.  Risks associated with continuation of potentially inappropriate antihypertensive medications in older adults receiving hemodialysis.

Authors:  Rasheeda K Hall; Sarah Morton; Jonathan Wilson; Patti L Ephraim; L Ebony Boulware; Wendy L St Peter; Cathleen Colón-Emeric; Jane Pendergast; Julia J Scialla
Journal:  BMC Nephrol       Date:  2021-06-19       Impact factor: 2.585
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.